Dr. Hedman clinical data
-
Biologics
Intralink-Spine’s Réjuve™ Treatment: Turning Skeptics Into Believers
August 01, 2017 LEXINGTON, Ky.–(BUSINESS WIRE)–Based on 12-month follow-up clinical data from its safety and feasibility study, Intralink-Spine, Inc. (ILS) indicates that…
Read More »